The DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Abstract
OBJECTIVES: Patients with RA have an increased prevalence of cardiovascular disease (CVD). This is due to traditional risk factors and the effects of chronic inflammation. MTX is the first-choice DMARD in RA. We performed a systematic literature review to determine whether MTX affects the risk of CVD in patients with RA. METHODS: We searched Medline, Embase, Cochrane database, database of abstracts of reviews of effects, health technology assessment and Science Citation Index from 1980 to 2008. Conference proceedings (British Society of Rheumatology, ACR and EULAR) were searched from 2005 to 2008. Papers were included if they assessed the relationship between MTX use and CVD in patients with RA. Two reviewers independently assessed each title and abstract for relevance and quality. RESULTS: A total of 2420 abstracts were identified, of which 18 fulfilled the inclusion criteria. Two studies assessed the relationship between MTX use and CVD mortality, one demonstrated a significant reduction in CVD mortality and the second a trend towards reduction. Five studies considered all-cause CVD morbidity. Four demonstrated a significant reduction in CVD morbidity and the fifth a trend towards reduction. MTX use in the year prior to the development of RA decreased the risk of CVD for 3-4 years. Four studies considered myocardial infarction, one demonstrated a decreased risk and three a trend towards decreased risk with MTX use. CONCLUSION: The current evidence suggests that MTX use is associated with a reduced risk of CVD events in patients with RA. This suggests that reducing the inflammation in RA using MTX not only improves disease-specific outcomes but may also reduce collateral damage such as atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Non-randomized observational studies report reductions in rates of vascular events and cardiovascular death among both rheumatoid arthritis and psoriasis patients being treated with weekly methotrexate in doses ranging from 10 to 20 mg.187,188”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [187]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000344393.60303.0a · Cited by 3,641
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531
Being big or growing fast: systematic review of size and growth in infancy and later obesity
Baird, J., Fisher, D., Lucas, P., Kleijnen, J., Roberts, H., & Law, C. (2005) · BMJ · doi:10.1136/bmj.38586.411273.e0 · Cited by 1,185
Self-citationMethotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. Á., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,133
Cardiovascular Risk and Inhibition of Cyclooxygenase
McGettigan, P., & Henry, D. A. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,106
Cardiovascular death in rheumatoid arthritis: A population‐based study
Kremers, H. M., Nicola, P., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 941
Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis
Sattar, N. A., McCarey, D. W., Capell, H. A., & McInnes, I. B. (2003) · Circulation · doi:10.1161/01.cir.0000099844.31524.05 · Cited by 932
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
Weinblatt, M. E., Coblyn, J. S., Fox, D. A., Fraser, P. A., Holdsworth, D. E., Glass, D. N., & Trentham, D. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503283121303 · Cited by 872
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645
Research works printed but not linked: 11
- Symmons, 1998, The Journal of Rheumatology, 25, 1072
- 1985, CLINICAL AND IMMUNOLOGIC EFFECTS IN A RANDOMIZED DOUBLEBLIND STUDY ANN INTERN MED, 103, 489
- 1985, A CONTROLLED CLINICAL TRIAL ARTHRITIS RHEUM, 28, 721
- Thompson, 1984, The Journal of Rheumatology, 11, 760
- 2008, Rheumatology, 47, ii49
- 2006, Annals of the Rheumatic Diseases, 65, 307
- 2008, Arthritis and rheumatism, 56, 688
- 2007, Arthritis and rheumatism, 56, S293
- GOODSON, 2008, The Journal of Rheumatology, 35, 945
- Seriolo, 2008, Clinical and experimental rheumatology, 26, 159
- Morgan, 1998, The Journal of Rheumatology, 25, 441
Cited by
Sorted by citations
Items 301–357 of 357
Богмат, Л. Ф., Ніконова, В. В., Шевченко, Н. С., & Миколаївна, Б. І. (2021) · CHILD`S HEALTH · doi:10.22141/2224-0551.16.2.2021.229873 · Cited by 1
Gohlke, H., Albus, C., Bönner, G., Darius, H., Eckert, S., Gohlke-Bärwolf, C., Gysan, D. B., Hahmann, H., Halle, M., Hambrecht, R., et al. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0421-z
The Effects of Methotrexate and Genetic Polymorphisms on the Folate/Homocysteine Pathway
Summers, C. (2011) · Scholarly Commons (University of Pennsylvania)
Gohlke, H., Albus, C., Bönner, G., Darius, H., Eckert, S., Gohlke-Bärwolf, C., Gysan, D. B., Hahmann, H., Halle, M., Hambrecht, R., et al. (2013) · Der Kardiologe · doi:10.1007/s12181-012-0468-x
Evaluación de la actividad inflamatoria mediante ultrasonografía en la artritis reumatoide
Naredo, E. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Tierney, M. (2013) · University of Limerick Institutional Repository (University of Limerick) · doi:10.34961/10340
Determinants of cardiovascular risk in current rheumatic practice
Meek, I. (2014) · University of Twente Research Information · doi:10.3990/1.9789461086174
Riesgo aterosclerótico en mujeres de mediana edad con artritis reumatoide
Santos-Altamirano, A., Rodríguez-Falcón, M., Meaney, A., Izaguirre-Gutiérrez, F., Velázquez, H., Rubio‐Gayosso, I., Nájera, N., Domínguez-Borgúa, A., & Meaney, E. (2015) · Cardiovascular and Metabolic Science
Kim, J. H., Kang, J. W., Kim, N. R., Bae, G. B., Lee, S.-K., Im, C. H., Nam, E. J., & Kang, Y. M. (2012) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2012.19.1.30
Müller‐Ladner, U., Tarner, I. H., Hamm, C. W., & Lange, U. (2010) · F1000 Medicine Reports · doi:10.3410/m2-27
Warum die rheumatoide Arthritis den Kardiologen braucht
Pieringer, H., & Hoppe, U. C. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0460-5
Furer, V., Fayad, Z. A., Farkouh, M. E., Rosenbaum, D. H., & Greenberg, J. D. (2011) · Drug Development Research · doi:10.1002/ddr.20482
Biological relevance and prognostic significance of radial artery intima-media thickness
Eklund, C. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Rheumatoid arthritis and cardiac disease
González-Mayda, M., Sen, D., & Brasington, R. (2014) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.14.40
From THE INSTITUTE OF ENVIRONMENTAL MEDICINE
Giuseppe, D. D. (2014)
Örnek, Z., Işık, M., Yeşil, N. K., Doğan, İ., Şahin, H., & BAKİ, A. E. (2015) · Open Journal of Rheumatology and Autoimmune Diseases · doi:10.4236/ojra.2015.54017
Methotrexate and cardiovascular events
Shah, A. R. (2015) · Scholarship@Western (Western University)
Baden-Baden, A.-R., Innere, A., & Hämatologie, M. V. (2013)
Santos-Altamirano, A., Rodríguez-Falcón, M., Meaney, A., Gutiérrez-Salmeán, G., Velázquez, H., Rubio‐Gayosso, I., Nájera, N., Ceballos, G. M., & Meaney, E. (2015)
Mechanisms of vascular protection in chronic inflammatory disease
Thornton, C. C. (2014) · Spiral (Imperial College London) · doi:10.25560/26595
Heart Failure and Inflammatory Arthritis: the Relationship of Systemic Inflammation
Jandali, B., Tang, W. H. W., & Husni, M. E. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0497-2
Rheumatoid Arthritis Management for General Internists
Uh, M., & Collins, D. (2013) · Canadian Journal of General Internal Medicine · doi:10.22374/cjgim.v8i0.104
Spasovski, D. (2015) · Clinical Medical Reviews and Case Reports · doi:10.23937/2378-3656/1410046
Pharmacological management of cardiovascular disease in patients with rheumatoid arthritis
Rollefstad, S., Ikdahl, E., & Semb, A. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-26782-1_5
(2015) · Emergency Medicine Open Access · doi:10.4172/2165-7548.1000271
The burden of subclinical synovitis in gout
Chowalloor, P. (2014) · UWA Profiles and Research Repository (UWA)
Cardiac Effects of Antirheumatic Drugs
Szekanecz, Z. (2017) · Technical report · doi:10.1016/b978-0-12-803997-7.00020-x
Tsalamandris, S., Oikonomou, E. K., Latsios, G., & Tousoulis, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811908-2.00013-1
Management of rheumatoid arthritis in primary care
Perry, M. A. (2017) · Nurse Prescribing · doi:10.12968/npre.2017.15.10.498
Outcomes of Comorbidities with Biologic and Systemic Agents
Noe, M. H., & Gelfand, J. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-66884-0_8
Nichtarteriitische anteriore ischämische Optikusneuropathie bei Patienten mit rheumatoider Arthritis
Pahor, A., Pahor, D., & Gračner, T. (2018) · Spektrum der Augenheilkunde · doi:10.1007/s00717-018-0409-6
Cardiovascular Risk in Rheumatic Disease
Gabriel, S. E., & Symmons, D. P. M. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00036-0
Management der rheumatoiden Arthritis
Keyßer, G., & Schäfer, C. (2019) · CME · doi:10.1007/s11298-019-6900-9
Fiehn, C., Keyßer, G., & Lorenz, H. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0887-2
A comparative study of CPH 82 and methotrexate in cases of rheumatoid arthritis
Gupta, A. K., Sharma, R., & Gillani, Z. (2019) · International Journal of Orthopaedics Sciences · doi:10.22271/ortho.2019.v5.i2a.2482
Risco cardiovascular na artrite reumatoide
Torigoe, D. Y., & Laurindo, I. M. M. (2015) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2015.14.4.6-12
(2012) · CRC Press eBooks · doi:10.1201/b11608-7
(2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328346809c
Nemirovski, K. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8904
Gohlke, H., Albus, C., Bönner, G., Darius, H., Eckert, S., Gohlke-Bärwolf, C., Gysan, D. B., Hahmann, H., Halle, N., Hambrecht, R., et al. (2012) · Der Kardiologe · doi:10.1007/s12181-011-0383-6
Kaski, J. C., & Carro, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734408703.793563429
Aronow, W. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734408703.793557972
Khasan, I., Ibrat, A., Islomovich, S. I., Sukhrobovna, R. M., Исламова, К., & Shuxrat, Z. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns8.13363
Considerações acerca de Cardiopatias de Doenças Reumáticas
de Andrade, P. I. R., Gomes, B. A., Santana, C. D. L., Souza, Y. J. R., Callou, P. H. C., & Tavares, J. M. (2023) · ID on line REVISTA DE PSICOLOGIA · doi:10.14295/idonline.v17i65.3637
Cardio-Rheumatology and Women’s Hearts
Akhtari, S., & Harvey, P. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_14
Advances in Anti-inflammatory Therapies for Cardiovascular Disease and Atherosclerosis
Noman, A. A., Sejuti, S. R., Anuva, N. J., Nabin, M. N. R., Noman, M. J. I., Islam, M. H., Rahman, A., Tanme, T. A., Afrose, F., Hosen, M. N., et al. (2025) · Current Signal Transduction Therapy · doi:10.2174/0115743624366056250407071501
Cardio-rheumatology: present and future. Part II
Ma, Y., Wang, Z., Vi, M., Trofimov, E. A., & Bashkinov, R. A. (2025) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov637317
IMPACTO DE LOS TRATAMIENTOS SISTÉMICOS DE LA PSORIASIS EN LOS FACTORES DE RIESGO CARDIOVASCULAR
Carrascosa, J. C. R. (2012) · Elsevier eBooks · doi:10.1016/b978-84-9022-693-3.50007-4
Kante, A., Mghaeith, S., Dunogué, B., BEREZNE, A., Revel, M., Comarmond, C., Chassagnon, G., Mouthon, L., & Chaigne, B. (2026) · RMD Open · doi:10.1136/rmdopen-2025-006562
Gordeev, A. V., Matyanova, E. V., Galushko, E. A., & Zotkin, E. G. (2026) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2026-1-54-62
Is methotrexate still a first-line treatment in rheumatoid arthritis?
Bahrani, S., & Edwards, C. J. (2026) · Joint Bone Spine · doi:10.1016/j.jbspin.2026.106046
Self-citationZhuo, C., Chen, L., Sun, X., Chen, T., Cai, H., & Hu, X. (2026) · Global Heart · doi:10.5334/gh.1526
Cerebrovascular integrity maintenance and inflammation in atherosclerosis animal models
Cataldo, V. D. (2016) · theses.fr (ABES) · doi:10.70675/7b5a6c4bz3377z40fezbf48z5da7afd1a502
Immune-Mediated Inflammatory Rheumatic Diseases
Santos, M. J., Cordeiro, A. C., & Gil, V. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-16018-4_6
Warum die rheumatoide Arthritis den Kardiologen braucht
Pieringer, H., & Hoppe, U. C. (2013) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1198-6
Metadata
- Authors
- Westlake, S. L., Colebatch, A. N., Baird, J., Kiely, P., Quinn, M., Choy, E., Ostor, A. J. K., & Edwards, C. J.
- Affiliations
- King's College London (GB)
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-27
- Volume
- 49
- Issue
- 2
- Pages
- 295-307
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2100260684
- Cited by
- 357
- References
- 57
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 15 · 2019: 26 · 2018: 20 · 2017: 25 · 2016: 32 · 2015: 38 · 2014: 25 · 2013: 33 · 2012: 42
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lara D. Veeken (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- methotrexate, rheumatoid arthritis, cardiovascular disease, cardiovascular mortality, cardiovascular morbidity, myocardial infarction, atherosclerosis, disease-modifying antirheumatic drugs, chronic inflammation
- MeSH terms
- Arthritis, Rheumatoid, Cardiovascular Diseases, Humans, Immunosuppressive Agents, Insulin Resistance, Lipids, Methotrexate, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
